Cheap generics drug company
mardi 4 février 2020 à 01:00*Sick of Big Pharma’s pricing, health insurers pledge $55M for cheap generics.*
Creating a drug company with other motives aside from profit is a good thing to do. Its competition could hold back other companies from gouging. However, there is a danger that the other companies could get out of that business or merge. That could lead to even less competition.
I hope the founders have taken very firm measures to prevent this company from being co-opted later and turned into a monopolistic super-gouger.